Mitochondrial complex I deficiency in Parkinson's disease.

doi:10.1016/S0140-6736(89)92366-0

Journal ArticleDOI

Mitochondrial complex I deficiency in Parkinson's disease.

Anthony H.V. Schapira, +5 more

- 03 Jun 1989 -

The Lancet

- Vol. 60, Iss: 8649, pp 1269-1269

Chats0

About:

This article is published in The Lancet.The article was published on 1989-06-03. It has received 1548 citations till now. The article focuses on the topics: NAD(P)H Dehydrogenase (Quinone) & Substantia nigra.

Citations

PDF

Open Access

More filters

Journal ArticleDOI

Does Levodopa Accelerate Parkinson’s Disease?

Tanya Simuni, +1 more

- 01 Jun 1999 -

Drugs & Aging

TL;DR: Evidence for and against levodopa neurotoxicity and the implications of the ‘levodopa controversy’ on clinical practice are reviewed.

...read moreread less

Journal ArticleDOI

Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling.

Pooja Jadiya, +2 more

- 07 Jul 2021 -

Acta neuropathologica communications

TL;DR: In this paper, the authors provide a comprehensive review of the literature and interpret that defective mitochondrial metabolism is upstream and primary to protein aggregation and other dogmatic hypotheses of NDDs.

...read moreread less

Journal ArticleDOI

UCP4 is a target effector of the NF-κB c-Rel prosurvival pathway against oxidative stress.

Jessica Wing-Man Ho, +8 more

- 15 Jul 2012 -

Free Radical Biology and Medicine

TL;DR: Protective effects of c-Rel overexpression in H(2)O(2)-induced oxidative stress were significantly reduced after UCP4 knockdown, indicating that UCP 4 is a target effector gene of the NF-κB c- Rel prosurvival pathway to mitigate the effects of oxidative stress.

...read moreread less

Journal ArticleDOI

Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease.

Jacob E. Simmering, +4 more

- 01 Apr 2021 -

JAMA Neurology

TL;DR: In this article, the authors used active comparator control and propensity score-matched data from Danish nationwide health registries to determine whether use of terazosin, doxaziosin, and alfuzosin is associated with a decreased risk of developing Parkinson disease.

...read moreread less

Journal Article

Treatment of parkinson's disease

Michael J. Aminoff

- 01 Sep 1994 -

Western Journal of Medicine

TL;DR: Dopamine agonists are also helpful and, when taken with low doses of levodopa, often provide sustained benefit with fewer side effects; novel agonists and new methods for their administration are therefore under study.

...read moreread less